Currently, there is no specific cure for familial drusen, but proactive management and emerging therapies offer ways to address the condition and its potential complications. The primary approach to managing familial drusen involves regular observation by an eye care professional to monitor the health of the retina and the progression of the drusen.
One of the main concerns with familial drusen is the potential development of choroidal neovascular membranes (CNVM)—abnormal blood vessels that grow beneath the retina and can leak fluid or bleed, leading to rapid vision loss. If CNVM occurs, it is typically treated with intravitreal anti-VEGF injections. Medications such as bevacizumab have been shown to be effective in reducing fluid, stabilizing vision, and preventing further damage in these cases.
Researchers have also explored the use of laser treatments to address drusen deposits. Some studies and case reports have indicated that sub-threshold or nanosecond laser treatments may help decrease drusen volume and improve retinal function, though these approaches are still considered experimental and are not universally adopted as standard care.
Looking to the future, the landscape of treatment is expanding. Investigational therapies, including regenerative cell treatments like the SVT-001 clinical trial, aim to restore retinal health. Additionally, ongoing research into the genetic and molecular pathways of the disease may eventually lead to targeted gene therapies or medications that can prevent drusen formation altogether.
Patients are encouraged to maintain a healthy lifestyle, including a diet rich in leafy greens and UV protection for their eyes, to support overall retinal health. Always consult your healthcare provider to discuss the most appropriate management plan and to stay informed about new treatment options.